SIMILAR PATTERNS OF AMINO ACIDS FOR 6A5Z_D_9CRD501

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a1s ORNITHINE
CARBAMOYLTRANSFERASE


(Pyrococcus
furiosus)
PF00185
(OTCace)
PF02729
(OTCace_N)
5 ILE A  23
ALA A 300
ALA A  27
LEU A 139
ALA A 140
None
1.06A 6a5zD-1a1sA:
undetectable
6a5zD-1a1sA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aha ALPHA-MOMORCHARIN

(Momordica
charantia)
PF00161
(RIP)
5 ALA A 135
ALA A 150
ILE A 155
LEU A 132
ALA A 131
None
None
ADE  A 339 (-4.1A)
None
None
1.10A 6a5zD-1ahaA:
undetectable
6a5zD-1ahaA:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dab P.69 PERTACTIN

(Bordetella
pertussis)
PF03212
(Pertactin)
5 ALA A 387
ALA A 357
LEU A 383
ALA A 384
ILE A 310
None
0.97A 6a5zD-1dabA:
undetectable
6a5zD-1dabA:
10.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ffv CUTL, MOLYBDOPROTEIN
OF CARBON MONOXIDE
DEHYDROGENASE


(Hydrogenophaga
pseudoflava)
PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2)
5 ILE B 574
ALA B 577
ALA B 578
ILE B 545
ALA B 640
None
1.01A 6a5zD-1ffvB:
undetectable
6a5zD-1ffvB:
7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gq2 MALIC ENZYME

(Columba livia)
PF00390
(malic)
PF03949
(Malic_M)
5 ILE A 530
ALA A 534
ILE A 553
LEU A 483
ALA A 540
None
1.00A 6a5zD-1gq2A:
undetectable
6a5zD-1gq2A:
8.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j0n XANTHAN LYASE

(Bacillus sp.
GL1)
PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N)
5 ALA A 106
ALA A 107
LEU A  60
ALA A  61
LEU A 165
None
1.22A 6a5zD-1j0nA:
undetectable
6a5zD-1j0nA:
7.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n60 CARBON MONOXIDE
DEHYDROGENASE SMALL
CHAIN


(Oligotropha
carboxidovorans)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 ILE A 149
ALA A 152
ALA A 153
LEU A  90
ALA A  89
None
1.02A 6a5zD-1n60A:
undetectable
6a5zD-1n60A:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmo HYPOTHETICAL PROTEIN
YBGI


(Escherichia
coli)
PF01784
(NIF3)
5 ILE A 179
ALA A 182
ALA A 183
ALA A 169
ILE A 200
None
0.86A 6a5zD-1nmoA:
undetectable
6a5zD-1nmoA:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p31 UDP-N-ACETYLMURAMATE
--ALANINE LIGASE


(Haemophilus
influenzae)
PF01225
(Mur_ligase)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M)
5 ILE A 454
ALA A 456
GLN A 457
ILE A 399
LEU A 469
None
1.10A 6a5zD-1p31A:
undetectable
6a5zD-1p31A:
12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tcs TRICHOSANTHIN

(Trichosanthes
kirilowii)
PF00161
(RIP)
5 ALA A 135
ALA A 150
ILE A 155
LEU A 132
ALA A 131
None
None
NDP  A 280 (-3.9A)
None
None
1.11A 6a5zD-1tcsA:
undetectable
6a5zD-1tcsA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tht THIOESTERASE

(Vibrio harveyi)
PF02273
(Acyl_transf_2)
5 ILE A 111
ALA A 113
ALA A 135
ILE A 204
ALA A 117
None
1.17A 6a5zD-1thtA:
undetectable
6a5zD-1thtA:
13.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1uhl RETINOIC ACID
RECEPTOR RXR-BETA


(Homo sapiens)
PF00104
(Hormone_recep)
12 ILE A 339
ALA A 342
ALA A 343
GLN A 346
ILE A 381
PHE A 384
ARG A 387
LEU A 397
ALA A 398
ILE A 416
CYH A 503
LEU A 507
MEI  A1001 (-3.8A)
MEI  A1001 (-3.1A)
MEI  A1001 (-3.3A)
None
MEI  A1001 ( 4.9A)
MEI  A1001 (-4.5A)
MEI  A1001 (-3.6A)
MEI  A1001 ( 4.4A)
MEI  A1001 (-3.4A)
None
MEI  A1001 (-4.0A)
MEI  A1001 (-4.6A)
0.62A 6a5zD-1uhlA:
35.9
6a5zD-1uhlA:
79.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ukw ACYL-COA
DEHYDROGENASE


(Thermus
thermophilus)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 ILE A 117
ALA A 120
LEU A 150
ALA A 151
ILE A  55
None
0.93A 6a5zD-1ukwA:
undetectable
6a5zD-1ukwA:
13.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w52 PANCREATIC LIPASE
RELATED PROTEIN 2


(Equus caballus)
PF00151
(Lipase)
PF01477
(PLAT)
5 ILE X 134
ALA X 163
ILE X 104
PHE X  74
ALA X 160
None
1.16A 6a5zD-1w52X:
undetectable
6a5zD-1w52X:
13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xdi RV3303C-LPDA

(Mycobacterium
tuberculosis)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ILE A 457
ALA A 461
ALA A 460
LEU A 443
ALA A 444
None
1.13A 6a5zD-1xdiA:
undetectable
6a5zD-1xdiA:
11.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xiu RXR-LIKE PROTEIN

(Biomphalaria
glabrata)
PF00104
(Hormone_recep)
12 ILE A 242
ALA A 245
ALA A 246
GLN A 249
ILE A 284
PHE A 287
ARG A 290
LEU A 300
ALA A 301
ILE A 319
CYH A 406
LEU A 410
9CR  A 201 ( 4.4A)
9CR  A 201 (-3.6A)
9CR  A 201 (-3.6A)
9CR  A 201 (-4.1A)
None
9CR  A 201 (-4.7A)
9CR  A 201 (-2.8A)
9CR  A 201 (-4.4A)
9CR  A 201 (-3.4A)
None
9CR  A 201 (-3.6A)
9CR  A 201 ( 4.8A)
0.39A 6a5zD-1xiuA:
33.0
6a5zD-1xiuA:
75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xls RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
LEU A 436
9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
0.31A 6a5zD-1xlsA:
35.4
6a5zD-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yd9 CORE HISTONE
MACRO-H2A.1


(Rattus
norvegicus)
PF01661
(Macro)
5 ILE A 135
ALA A 147
ILE A 155
LEU A 111
ILE A 130
None
1.22A 6a5zD-1yd9A:
undetectable
6a5zD-1yd9A:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yxa SERINE (OR CYSTEINE)
PROTEINASE
INHIBITOR, CLADE A,
MEMBER 3N


(Mus musculus)
PF00079
(Serpin)
5 ILE A 113
ALA A  83
ILE A  50
ALA A  80
LEU A 105
None
1.15A 6a5zD-1yxaA:
undetectable
6a5zD-1yxaA:
14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a19 EUKARYOTIC
TRANSLATION
INITIATION FACTOR 2
ALPHA SUBUNIT


(Saccharomyces
cerevisiae)
PF00575
(S1)
PF07541
(EIF_2_alpha)
5 ILE A 129
ILE A 110
PHE A 144
LEU A 133
CYH A 114
None
1.01A 6a5zD-2a19A:
undetectable
6a5zD-2a19A:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2be4 HYPOTHETICAL PROTEIN
LOC449832


(Danio rerio)
PF13202
(EF-hand_5)
PF13499
(EF-hand_7)
5 ILE A  83
ALA A  80
ILE A  16
LEU A  84
LEU A  33
None
1.14A 6a5zD-2be4A:
undetectable
6a5zD-2be4A:
16.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bg5 PHOSPHOENOLPYRUVATE-
PROTEIN KINASE


(Caldanaerobacter
subterraneus)
PF02896
(PEP-utilizers_C)
5 ALA A 491
ILE A 451
ALA A 443
ILE A 481
LEU A 518
None
1.15A 6a5zD-2bg5A:
undetectable
6a5zD-2bg5A:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bx6 XRP2 PROTEIN

(Homo sapiens)
PF07986
(TBCC)
5 ILE A 254
ILE A 166
PHE A 167
LEU A 300
ALA A 299
None
1.12A 6a5zD-2bx6A:
undetectable
6a5zD-2bx6A:
12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c4n PROTEIN NAGD

(Escherichia
coli)
PF13242
(Hydrolase_like)
PF13344
(Hydrolase_6)
5 ILE A  31
ILE A 247
PHE A  27
ALA A  25
ILE A   3
None
1.15A 6a5zD-2c4nA:
undetectable
6a5zD-2c4nA:
17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fv2 RCD1 REQUIRED FOR
CELL
DIFFERENTIATION1
HOMOLOG


(Homo sapiens)
PF04078
(Rcd1)
5 ALA A  85
GLN A  82
LEU A 130
ALA A 129
LEU A  51
None
0.75A 6a5zD-2fv2A:
undetectable
6a5zD-2fv2A:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fzw ALCOHOL
DEHYDROGENASE CLASS
III CHI CHAIN


(Homo sapiens)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 ILE A 249
ALA A 280
ALA A 277
LEU A 253
ILE A 223
None
None
None
None
NAD  A1377 (-4.0A)
1.15A 6a5zD-2fzwA:
undetectable
6a5zD-2fzwA:
14.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2gl8 RETINOIC ACID
RECEPTOR RXR-GAMMA


(Homo sapiens)
PF00104
(Hormone_recep)
7 ILE A  89
PHE A  92
ARG A  95
LEU A 105
ALA A 106
ILE A 124
CYH A 211
None
0.69A 6a5zD-2gl8A:
28.2
6a5zD-2gl8A:
77.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hcs RNA-DIRECTED RNA
POLYMERASE (NS5)


(West Nile virus)
PF00972
(Flavi_NS5)
5 ALA A 764
ALA A 781
ILE A 872
ALA A 760
LEU A 891
None
1.20A 6a5zD-2hcsA:
undetectable
6a5zD-2hcsA:
8.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2nxx ULTRASPIRACLE (USP,
NR2B4)


(Tribolium
castaneum)
PF00104
(Hormone_recep)
5 ILE A 256
PHE A 259
ARG A 262
LEU A 272
ALA A 273
None
0.62A 6a5zD-2nxxA:
25.4
6a5zD-2nxxA:
52.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2nxx ULTRASPIRACLE (USP,
NR2B4)


(Tribolium
castaneum)
PF00104
(Hormone_recep)
5 ILE A 256
PHE A 259
ARG A 262
LEU A 272
CYH A 378
None
0.73A 6a5zD-2nxxA:
25.4
6a5zD-2nxxA:
52.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pp3 L-TALARATE/GALACTARA
TE DEHYDRATASE


(Salmonella
enterica)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ILE A 135
ALA A 131
ALA A  93
ALA A 128
ILE A  28
None
1.15A 6a5zD-2pp3A:
undetectable
6a5zD-2pp3A:
12.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ppl PANCREATIC
LIPASE-RELATED
PROTEIN 1


(Homo sapiens)
PF00151
(Lipase)
PF01477
(PLAT)
5 ALA A 180
ILE A 121
ALA A 177
ILE A  78
LEU A  72
None
1.22A 6a5zD-2pplA:
undetectable
6a5zD-2pplA:
9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pvs PANCREATIC
LIPASE-RELATED
PROTEIN 2


(Homo sapiens)
PF00151
(Lipase)
PF01477
(PLAT)
5 ILE A 132
ALA A 161
ILE A 102
PHE A  72
ALA A 158
None
1.21A 6a5zD-2pvsA:
undetectable
6a5zD-2pvsA:
11.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2q60 RETINOID X RECEPTOR

(Polyandrocarpa
misakiensis)
PF00104
(Hormone_recep)
6 ILE A 185
PHE A 188
ARG A 191
ALA A 202
ILE A 220
CYH A 307
None
0.55A 6a5zD-2q60A:
27.1
6a5zD-2q60A:
54.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vbi PYRUVATE
DECARBOXYLASE


(Acetobacter
pasteurianus)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ILE A 152
ALA A 155
ILE A  97
ALA A 134
LEU A  18
None
1.15A 6a5zD-2vbiA:
undetectable
6a5zD-2vbiA:
10.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w55 XANTHINE
DEHYDROGENASE


(Rhodobacter
capsulatus)
PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2)
5 ALA B 588
ALA B 587
ILE B 473
ALA B 592
ILE B 506
None
1.08A 6a5zD-2w55B:
undetectable
6a5zD-2w55B:
7.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w55 XANTHINE
DEHYDROGENASE


(Rhodobacter
capsulatus)
PF01315
(Ald_Xan_dh_C)
PF02738
(Ald_Xan_dh_C2)
5 ILE B 585
ALA B 588
ALA B 587
ILE B 473
ALA B 592
None
1.13A 6a5zD-2w55B:
undetectable
6a5zD-2w55B:
7.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y2w ARABINOFURANOSIDASE

(Bifidobacterium
longum)
PF06964
(Alpha-L-AF_C)
5 ILE A 417
ALA A 425
ALA A 419
ILE A  79
LEU A  99
None
1.11A 6a5zD-2y2wA:
undetectable
6a5zD-2y2wA:
9.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yqu 2-OXOGLUTARATE
DEHYDROGENASE E3
COMPONENT


(Thermus
thermophilus)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ILE A 297
ALA A 299
ILE A   7
ALA A 320
LEU A 271
None
0.94A 6a5zD-2yquA:
undetectable
6a5zD-2yquA:
11.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ci0 PSEUDOPILIN GSPK

(Escherichia
coli)
PF03934
(T2SSK)
5 ILE K 218
ALA K 221
LEU K 119
ALA K 118
LEU K 271
None
1.12A 6a5zD-3ci0K:
undetectable
6a5zD-3ci0K:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cpi RAB GDP-DISSOCIATION
INHIBITOR


(Saccharomyces
cerevisiae)
PF00996
(GDI)
5 GLN G 329
ILE G 364
LEU G 328
ILE G 387
CYH G 313
None
0.99A 6a5zD-3cpiG:
undetectable
6a5zD-3cpiG:
10.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d8u PURR TRANSCRIPTIONAL
REGULATOR


(Vibrio
parahaemolyticus)
PF13377
(Peripla_BP_3)
5 ALA A 311
ALA A 310
LEU A  96
ALA A  95
ILE A  76
None
0.84A 6a5zD-3d8uA:
undetectable
6a5zD-3d8uA:
13.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dzu RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
PF00105
(zf-C4)
10 ALA A 271
ALA A 272
GLN A 275
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ILE A 345
CYH A 432
LEU A 436
9CR  A7223 (-3.5A)
9CR  A7223 (-4.2A)
9CR  A7223 (-4.6A)
None
9CR  A7223 (-4.5A)
9CR  A7223 (-3.7A)
9CR  A7223 (-3.8A)
9CR  A7223 ( 4.9A)
9CR  A7223 (-3.8A)
9CR  A7223 ( 4.7A)
0.53A 6a5zD-3dzuA:
34.2
6a5zD-3dzuA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dzu RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
PF00105
(zf-C4)
9 ALA A 272
GLN A 275
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
CYH A 432
LEU A 436
9CR  A7223 (-4.2A)
9CR  A7223 (-4.6A)
None
9CR  A7223 (-4.5A)
9CR  A7223 (-3.7A)
9CR  A7223 (-3.8A)
9CR  A7223 ( 4.7A)
9CR  A7223 (-3.8A)
9CR  A7223 ( 4.7A)
0.55A 6a5zD-3dzuA:
34.2
6a5zD-3dzuA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dzu RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
PF00104
(Hormone_recep)
PF00105
(zf-C4)
10 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ILE A 310
PHE A 313
ARG A 316
ILE A 345
CYH A 432
LEU A 436
9CR  A7223 (-3.9A)
9CR  A7223 (-3.5A)
9CR  A7223 (-4.2A)
9CR  A7223 (-4.6A)
None
9CR  A7223 (-4.5A)
9CR  A7223 (-3.7A)
9CR  A7223 ( 4.9A)
9CR  A7223 (-3.8A)
9CR  A7223 ( 4.7A)
0.50A 6a5zD-3dzuA:
34.2
6a5zD-3dzuA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3eyb NUCLEAR HORMONE
RECEPTOR RXR


(Branchiostoma
floridae)
PF00104
(Hormone_recep)
5 ILE A 339
PHE A 342
LEU A 355
ALA A 356
CYH A 461
None
0.79A 6a5zD-3eybA:
29.0
6a5zD-3eybA:
75.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fg2 PUTATIVE RUBREDOXIN
REDUCTASE


(Rhodopseudomonas
palustris)
PF07992
(Pyr_redox_2)
PF14759
(Reductase_C)
5 ILE P 245
ALA P 248
ALA P 249
ILE P  32
LEU P 104
None
None
None
FAD  P 449 ( 4.5A)
None
0.96A 6a5zD-3fg2P:
undetectable
6a5zD-3fg2P:
12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fvq FE(3+) IONS IMPORT
ATP-BINDING PROTEIN
FBPC


(Neisseria
gonorrhoeae)
PF00005
(ABC_tran)
5 ILE A   7
ILE A  35
LEU A   5
ILE A 217
LEU A  20
None
1.16A 6a5zD-3fvqA:
undetectable
6a5zD-3fvqA:
16.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hve GIGAXONIN
GIGAXONIN


(Homo sapiens;
Homo sapiens)
PF00651
(BTB)
PF07707
(BACK)
PF00651
(BTB)
5 ILE A  47
ALA A  50
LEU B  20
ALA B  19
LEU A  87
None
0.73A 6a5zD-3hveA:
undetectable
6a5zD-3hveA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i24 HIT FAMILY HYDROLASE

(Aliivibrio
fischeri)
PF01230
(HIT)
5 ILE A  80
ALA A  66
ILE A  59
ILE A  47
LEU A  37
None
NA  A 155 ( 4.1A)
None
NA  A 156 ( 3.9A)
None
1.08A 6a5zD-3i24A:
undetectable
6a5zD-3i24A:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iwz CATABOLITE
ACTIVATION-LIKE
PROTEIN


(Xanthomonas
campestris)
PF00027
(cNMP_binding)
PF00325
(Crp)
5 ILE A 133
ALA A 136
LEU A  22
ILE A 113
LEU A  91
None
0.98A 6a5zD-3iwzA:
undetectable
6a5zD-3iwzA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k5w CARBOHYDRATE KINASE

(Helicobacter
pylori)
PF01256
(Carb_kinase)
PF03853
(YjeF_N)
5 ALA A 296
ALA A 417
ILE A 273
CYH A 271
LEU A 269
None
1.10A 6a5zD-3k5wA:
undetectable
6a5zD-3k5wA:
12.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k96 GLYCEROL-3-PHOSPHATE
DEHYDROGENASE
[NAD(P)+]


(Coxiella
burnetii)
PF01210
(NAD_Gly3P_dh_N)
PF07479
(NAD_Gly3P_dh_C)
5 ILE A 135
ALA A 106
ALA A 133
ILE A 166
LEU A  80
None
0.85A 6a5zD-3k96A:
undetectable
6a5zD-3k96A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3msu CITRATE SYNTHASE

(Francisella
tularensis)
PF00285
(Citrate_synt)
5 ALA A 175
ALA A 176
LEU A 388
ALA A 384
ILE A 218
None
0.80A 6a5zD-3msuA:
undetectable
6a5zD-3msuA:
10.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nze PUTATIVE
TRANSCRIPTIONAL
REGULATOR,
SUGAR-BINDING FAMILY


(Paenarthrobacter
aurescens)
PF04198
(Sugar-bind)
5 ILE A 279
ALA A  98
GLN A  97
ILE A 112
LEU A 120
None
0.94A 6a5zD-3nzeA:
undetectable
6a5zD-3nzeA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oks 4-AMINOBUTYRATE
TRANSAMINASE


(Mycolicibacterium
smegmatis)
PF00202
(Aminotran_3)
5 ILE A 327
ALA A 331
ALA A 330
LEU A 298
ALA A 295
None
0.94A 6a5zD-3oksA:
undetectable
6a5zD-3oksA:
11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pei CYTOSOL
AMINOPEPTIDASE


(Francisella
tularensis)
PF00883
(Peptidase_M17)
PF02789
(Peptidase_M17_N)
5 ILE A  81
ALA A  85
GLN A  87
ILE A  96
LEU A  64
None
None
EDO  A 512 (-3.2A)
None
None
1.15A 6a5zD-3peiA:
undetectable
6a5zD-3peiA:
10.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qr8 BASEPLATE ASSEMBLY
PROTEIN V


(Escherichia
virus P2)
PF04717
(Phage_base_V)
5 ILE A  69
ALA A  71
ALA A  79
ILE A  23
CYH A  33
None
1.03A 6a5zD-3qr8A:
undetectable
6a5zD-3qr8A:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rqi RESPONSE REGULATOR
PROTEIN


(Burkholderia
pseudomallei)
PF00072
(Response_reg)
PF02954
(HTH_8)
5 ALA A  33
GLN A  32
ILE A  51
ALA A  16
ILE A  66
None
0.96A 6a5zD-3rqiA:
undetectable
6a5zD-3rqiA:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3upn PENICILLIN-BINDING
PROTEIN A


(Mycobacterium
tuberculosis)
PF00905
(Transpeptidase)
5 ALA A 231
ALA A 232
LEU A 298
ALA A 297
LEU A 243
None
1.10A 6a5zD-3upnA:
undetectable
6a5zD-3upnA:
10.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a1f REPLICATIVE DNA
HELICASE


(Helicobacter
pylori)
PF03796
(DnaB_C)
5 ILE A 201
ALA A 203
GLN A 354
ILE A 372
LEU A 352
None
1.12A 6a5zD-4a1fA:
undetectable
6a5zD-4a1fA:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b8b GENERAL NEGATIVE
REGULATOR OF
TRANSCRIPTION
SUBUNIT 1


(Saccharomyces
cerevisiae)
PF16417
(CNOT1_TTP_bind)
PF16418
(CNOT1_HEAT)
PF16419
(CNOT1_HEAT_N)
5 ILE A 741
ALA A 744
ALA A 745
LEU A 714
ALA A 715
None
0.80A 6a5zD-4b8bA:
undetectable
6a5zD-4b8bA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ecn LEUCINE-RICH REPEAT
PROTEIN


(Bacteroides
thetaiotaomicron)
PF14660
(DUF4458)
5 ILE A 305
ALA A 301
ALA A 370
GLN A 373
ILE A 465
None
1.09A 6a5zD-4ecnA:
undetectable
6a5zD-4ecnA:
6.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eco UNCHARACTERIZED
PROTEIN


(Bacteroides
eggerthii)
no annotation 5 ILE A 306
ALA A 302
ALA A 368
GLN A 371
ILE A 463
None
1.15A 6a5zD-4ecoA:
undetectable
6a5zD-4ecoA:
9.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fc4 NITRITE TRANSPORTER
NIRC


(Salmonella
enterica)
PF01226
(Form_Nir_trans)
5 ILE A  43
ALA A 120
LEU A 207
ALA A 206
ILE A  67
None
1.14A 6a5zD-4fc4A:
undetectable
6a5zD-4fc4A:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN


(Agrobacterium
fabrum)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ALA A 117
GLN A 118
LEU A 113
ILE A 245
LEU A 297
None
1.13A 6a5zD-4gfiA:
undetectable
6a5zD-4gfiA:
12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i1d ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN


(Bradyrhizobium
diazoefficiens)
PF13416
(SBP_bac_8)
5 ALA A 190
ALA A 189
ILE A 184
LEU A 213
ALA A 209
None
None
GOL  A 410 ( 4.9A)
None
None
1.06A 6a5zD-4i1dA:
undetectable
6a5zD-4i1dA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ia4 AQUAPORIN

(Spinacia
oleracea)
PF00230
(MIP)
5 ALA A 257
ALA A 258
GLN A 261
LEU A 110
ALA A 111
None
0.67A 6a5zD-4ia4A:
undetectable
6a5zD-4ia4A:
15.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4j5x RETINOIC ACID
RECEPTOR RXR-ALPHA,
NUCLEAR RECEPTOR
COACTIVATOR 1


(Homo sapiens)
no annotation 12 ILE D 268
ALA D 271
ALA D 272
GLN D 275
ILE D 310
PHE D 313
ARG D 316
LEU D 326
ALA D 327
ILE D 345
CYH D 432
LEU D 436
None
0.52A 6a5zD-4j5xD:
33.9
6a5zD-4j5xD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jx8 ENOYL-[ACYL-CARRIER-
PROTEIN] REDUCTASE
[NADH] FABI


(Escherichia
coli)
PF13561
(adh_short_C2)
5 ALA A 230
ALA A 229
ILE A 222
ARG A  30
LEU A 144
None
None
None
None
NAD  A 302 (-3.9A)
0.97A 6a5zD-4jx8A:
undetectable
6a5zD-4jx8A:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ky0 PROTON/GLUTAMATE
SYMPORTER, SDF
FAMILY


(Thermococcus
kodakarensis)
PF00375
(SDF)
5 ILE A 157
ALA A 160
PHE A 304
LEU A  68
ILE A 312
None
1.18A 6a5zD-4ky0A:
undetectable
6a5zD-4ky0A:
11.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mij TRAP DICARBOXYLATE
TRANSPORTER, DCTP
SUBUNIT


(Polaromonas sp.
JS666)
PF03480
(DctP)
5 ILE A 261
ALA A 265
ALA A 264
LEU A 146
ALA A 147
None
1.08A 6a5zD-4mijA:
undetectable
6a5zD-4mijA:
12.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nn1 TRANSCRIPTIONAL
REGULATOR


(Mycobacterium
tuberculosis)
PF00440
(TetR_N)
5 ILE A  12
ALA A  15
ALA A  16
GLN A  19
ALA A  35
None
0.49A 6a5zD-4nn1A:
undetectable
6a5zD-4nn1A:
17.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oyd APOPTOSIS REGULATOR
BHRF1


(Human
gammaherpesvirus
4)
PF00452
(Bcl-2)
5 ILE A   8
ALA A  11
LEU A  40
ILE A 154
LEU A  54
None
0.98A 6a5zD-4oydA:
undetectable
6a5zD-4oydA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4phb UNCHARACTERIZED
PROTEIN


(Ruminiclostridium
thermocellum)
PF14262
(Cthe_2159)
5 ILE A 210
ALA A 212
ILE A 246
ALA A 214
ILE A 203
None
1.15A 6a5zD-4phbA:
undetectable
6a5zD-4phbA:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B


(Homo sapiens)
PF10294
(Methyltransf_16)
5 ALA A 179
LEU A  63
ALA A  59
ILE A  80
LEU A 166
None
0.78A 6a5zD-4qpnA:
undetectable
6a5zD-4qpnA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tlv ADP-RIBOSYLATING
TOXIN CARDS


(Mycoplasma
pneumoniae)
PF02917
(Pertussis_S1)
5 ALA A 216
ILE A  37
LEU A 226
ALA A 229
LEU A 260
None
1.20A 6a5zD-4tlvA:
undetectable
6a5zD-4tlvA:
9.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uul L-LACTATE
DEHYDROGENASE


(Trichomonas
vaginalis)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 ALA A   4
GLN A  34
ILE A  24
ALA A  65
LEU A 256
None
1.00A 6a5zD-4uulA:
undetectable
6a5zD-4uulA:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yc6 CYCLIN-DEPENDENT
KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
5 ILE A 112
ILE A 136
LEU A 144
ALA A 145
LEU A 197
None
1.11A 6a5zD-4yc6A:
undetectable
6a5zD-4yc6A:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ykn PHOSPHATIDYLINOSITOL
3-KINASE REGULATORY
SUBUNIT
ALPHA,PHOSPHATIDYLIN
OSITOL
4,5-BISPHOSPHATE
3-KINASE CATALYTIC
SUBUNIT ALPHA
ISOFORM FUSION
PROTEIN


(Homo sapiens)
PF00017
(SH2)
PF00454
(PI3_PI4_kinase)
PF00613
(PI3Ka)
PF00792
(PI3K_C2)
PF00794
(PI3K_rbd)
PF02192
(PI3K_p85B)
PF16454
(PI3K_P85_iSH2)
5 ILE A1427
ILE A1336
LEU A1443
ALA A1442
ILE A1360
None
1.04A 6a5zD-4yknA:
undetectable
6a5zD-4yknA:
5.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ynv ACL4

(Chaetomium
thermophilum)
PF13432
(TPR_16)
5 ILE A  46
ALA A  49
ALA A  50
LEU A  41
ALA A  37
None
1.16A 6a5zD-4ynvA:
undetectable
6a5zD-4ynvA:
13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bt1 HAT1-INTERACTING
FACTOR 1


(Saccharomyces
cerevisiae)
no annotation 5 ALA A  41
ALA A  42
LEU A  33
ALA A  29
ILE A 245
None
0.63A 6a5zD-5bt1A:
undetectable
6a5zD-5bt1A:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dot CARBAMOYL-PHOSPHATE
SYNTHASE [AMMONIA],
MITOCHONDRIAL


(Homo sapiens)
PF00117
(GATase)
PF00988
(CPSase_sm_chain)
PF02142
(MGS)
PF02786
(CPSase_L_D2)
PF02787
(CPSase_L_D3)
5 ILE A 858
ILE A 851
LEU A 885
ILE A 873
LEU A 843
None
1.09A 6a5zD-5dotA:
undetectable
6a5zD-5dotA:
4.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dot CARBAMOYL-PHOSPHATE
SYNTHASE [AMMONIA],
MITOCHONDRIAL


(Homo sapiens)
PF00117
(GATase)
PF00988
(CPSase_sm_chain)
PF02142
(MGS)
PF02786
(CPSase_L_D2)
PF02787
(CPSase_L_D3)
5 ILE A 858
ILE A 851
PHE A 823
ILE A 873
LEU A 843
None
0.99A 6a5zD-5dotA:
undetectable
6a5zD-5dotA:
4.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g53 ADENOSINE RECEPTOR
A2A


(Homo sapiens)
PF00001
(7tm_1)
5 ILE A 200
ALA A 203
ALA A 204
GLN A 207
ILE A 238
None
1.23A 6a5zD-5g53A:
2.6
6a5zD-5g53A:
13.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ja1 ENTEROBACTIN
SYNTHASE COMPONENT F


(Escherichia
coli)
PF00501
(AMP-binding)
PF00550
(PP-binding)
PF00668
(Condensation)
PF00975
(Thioesterase)
PF13193
(AMP-binding_C)
5 ILE A 417
ALA A 421
GLN A 238
LEU A 239
ILE A 392
None
1.15A 6a5zD-5ja1A:
undetectable
6a5zD-5ja1A:
5.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5med ARACHIDONATE
15-LIPOXYGENASE


(Cyanothece sp.
PCC 8801)
PF00305
(Lipoxygenase)
5 GLN A 440
LEU A 342
ALA A 341
ILE A 540
LEU A 514
None
1.22A 6a5zD-5medA:
undetectable
6a5zD-5medA:
9.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n0g PRECORRIN-8X
METHYLMUTASE


(Rhodobacter
capsulatus)
no annotation 5 ILE A  73
ALA A  71
ALA A 130
LEU A  67
ALA A  66
None
0.96A 6a5zD-5n0gA:
undetectable
6a5zD-5n0gA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5npu ANC27

(synthetic
construct)
no annotation 5 ILE A 152
ALA A 155
ILE A  97
ALA A 134
LEU A  18
None
1.18A 6a5zD-5npuA:
undetectable
6a5zD-5npuA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohs -

(-)
no annotation 5 ILE A 257
ALA A 260
PHE A 541
LEU A 538
ALA A 539
None
0.82A 6a5zD-5ohsA:
undetectable
6a5zD-5ohsA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ojl IMINE REDUCTASE

(Aspergillus
terreus)
no annotation 5 ALA A  60
ILE A  68
ALA A  63
CYH A  70
LEU A  71
None
None
None
None
TXP  A 302 (-4.2A)
1.02A 6a5zD-5ojlA:
undetectable
6a5zD-5ojlA:
23.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5uan RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
no annotation 11 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
LEU A 436
9CR  A 503 (-4.0A)
9CR  A 503 (-3.5A)
9CR  A 503 (-3.5A)
9CR  A 503 (-3.8A)
9CR  A 503 ( 4.8A)
9CR  A 503 (-4.7A)
9CR  A 503 (-3.0A)
9CR  A 503 (-4.3A)
9CR  A 503 (-3.4A)
None
9CR  A 503 ( 4.8A)
0.45A 6a5zD-5uanA:
34.6
6a5zD-5uanA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5uan RETINOIC ACID
RECEPTOR RXR-ALPHA


(Homo sapiens)
no annotation 10 ILE A 268
ALA A 271
ALA A 272
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
CYH A 432
LEU A 436
9CR  A 503 (-4.0A)
9CR  A 503 (-3.5A)
9CR  A 503 (-3.5A)
9CR  A 503 ( 4.8A)
9CR  A 503 (-4.7A)
9CR  A 503 (-3.0A)
9CR  A 503 (-4.3A)
9CR  A 503 (-3.4A)
9CR  A 503 (-3.3A)
9CR  A 503 ( 4.8A)
0.52A 6a5zD-5uanA:
34.6
6a5zD-5uanA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5un0 PROTEASOME ASSEMBLY
CHAPERONE 2 (PAC2)
HOMOLOGUE RV2125


(Mycobacterium
tuberculosis)
PF09754
(PAC2)
5 ALA 1  21
ALA 1  20
ALA 1  32
CYH 1 111
LEU 1 114
None
1.19A 6a5zD-5un01:
undetectable
6a5zD-5un01:
14.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wq7 PUTATIVE TYPE II
SECRETION SYSTEM
PROTEIN D


(Escherichia
coli)
PF00263
(Secretin)
PF03958
(Secretin_N)
5 ILE A 158
ALA A 114
ILE A 143
LEU A 121
ALA A 118
None
0.99A 6a5zD-5wq7A:
undetectable
6a5zD-5wq7A:
9.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xgj PHOSPHATIDYLINOSITOL
4,5-BISPHOSPHATE
3-KINASE CATALYTIC
SUBUNIT ALPHA
ISOFORM


(Homo sapiens)
no annotation 5 ILE A 427
ILE A 336
LEU A 443
ALA A 442
ILE A 360
None
1.15A 6a5zD-5xgjA:
undetectable
6a5zD-5xgjA:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cuf -

(-)
no annotation 5 ILE 8  48
ALA 8  60
GLN 8  64
LEU 8  63
ILE 8  20
None
1.13A 6a5zD-6cuf8:
undetectable
6a5zD-6cuf8:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d95 -

(-)
no annotation 5 ILE A 129
ALA A 132
ALA A 133
LEU A 267
ALA A 266
None
0.60A 6a5zD-6d95A:
undetectable
6a5zD-6d95A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eux POLYMERASE BASIC
PROTEIN 2


(Influenza B
virus)
no annotation 5 ILE A 312
ALA A 315
ALA A 316
LEU A 505
ILE A 273
None
0.83A 6a5zD-6euxA:
undetectable
6a5zD-6euxA:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f5o POLYMERASE BASIC
PROTEIN 2


(Influenza B
virus)
no annotation 5 ILE C 312
ALA C 315
ALA C 316
LEU C 505
ILE C 273
None
0.90A 6a5zD-6f5oC:
undetectable
6a5zD-6f5oC:
25.58